Revvity Blog
Powering innovation from discovery to cure.

The mixed lymphocyte reaction (MLR): a classic assay for modern drug immune assessment.

The economic factors shaping expression system decisions and manufacturing strategies.

World tuberculosis day 2025: Raising awareness to support global TB control efforts.

Revolutionizing newborn screening: next-generation sequencing in genetic disease research.

Utilizing AlphaLISA technology to elucidate CDK2 signaling pathways in CCNE-1 amplified ovarian cancer.

How Mimix™ Reference Standards are generated, and how they can support your oncology research.

The role of bioinformatics in PGTM: streamlining precision with next-generation sequencing.

Unlocking biological questions with functional genomics.

Genetic testing: a critical tool for diagnosing rare disorders and enhancing patient care.

Detecting total and phospho-ser129 α-synuclein in preclinical models.
